Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. (Q54321441)

27 May 2018

title

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. (English)

1 reference

27 May 2018

0 references

6

1 reference

27 May 2018

author name string

Satoshi Serada

1

1 reference

27 May 2018

Minoru Fujimoto

2

1 reference

27 May 2018

Fumitaka Terabe

3

1 reference

27 May 2018

Hideki Iijima

4

1 reference

27 May 2018

Shinichiro Shinzaki

5

1 reference

27 May 2018

Tomoharu Ohkawara

7

1 reference

27 May 2018

Riichiro Nezu

8

1 reference

27 May 2018

Sachiko Nakajima

9

1 reference

27 May 2018

Taku Kobayashi

10

1 reference

27 May 2018

Scott Eric Plevy

11

1 reference

27 May 2018

Tetsuo Takehara

12

1 reference

27 May 2018

Tetsuji Naka

13

1 reference

27 May 2018

publication date

28 February 2012

1 reference

27 May 2018

Inflammatory Bowel Diseases

published in

1 reference

27 May 2018

volume

18

1 reference

27 May 2018

issue

11

1 reference

27 May 2018

page(s)

2169-2179

1 reference

27 May 2018

Diagnostics of inflammatory bowel disease

cites work

1 reference

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

21 January 2018

1 reference

Current management of severe ulcerative colitis

21 January 2018

1 reference

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

Use of the Crohn's disease activity index in clinical trials of biological agents

21 January 2018

1 reference

C-reactive protein as a marker for inflammatory bowel disease

21 January 2018

1 reference

Differing acute phase responses in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum

21 January 2018

1 reference

Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response

21 January 2018

1 reference

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses

21 January 2018

1 reference

Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma

21 January 2018

1 reference

Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin

21 January 2018

1 reference

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.22936

1 reference

27 May 2018

1 reference

27 May 2018